ARTICLE | Clinical News
Lyrica regulatory update
February 23, 2017 2:15 AM UTC
Pfizer and Eisai Co. Ltd. (Tokyo:4523, Tokyo, Japan) said Japan approved Lyrica pregabalin oral disintegrating (OD) tablets to treat neuropathic pain and pain associated with fibromyalgia. The GABA r...
BCIQ Target Profiles